Europe Canine Atopic Dermatitis Market Size & Outlook

The canine atopic dermatitis market in Europe is expected to reach a projected revenue of US$ 1,995.3 million by 2030. A compound annual growth rate of 9.7% is expected of Europe canine atopic dermatitis market from 2025 to 2030.
Revenue, 2024 (US$M)
$1,158.5
Forecast, 2030 (US$M)
$1,995.3
CAGR, 2025 - 2030
9.7%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe canine atopic dermatitis market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe canine atopic dermatitis market highlights

  • The Europe canine atopic dermatitis market generated a revenue of USD 1,158.5 million in 2024.
  • The market is expected to grow at a CAGR of 9.7% from 2025 to 2030.
  • In terms of segment, glucocorticoids was the largest revenue generating product in 2024.
  • MAbs is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2025 to 2030.


Europe data book summary

Market revenue in 2024USD 1,158.5 million
Market revenue in 2030USD 1,995.3 million
Growth rate9.7% (CAGR from 2025 to 2030)
Largest segmentGlucocorticoids
Fastest growing segmentMAbs
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGlucocorticoids, Antihistamines, Immunosuppressants, MAbs
Key market players worldwideZoetis Inc Class A, Merck & Co., Inc., Elanco, Boehringer Ingelheim International GmbH, Virbac SA, Vetoquinol SA, Biofelix Pharma Group, Dechra, Toray Industries Inc, Bioiberica, CEVA Inc, Bimeda


Other key industry trends

  • In terms of revenue, Europe region accounted for 30.1% of the global canine atopic dermatitis market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,386.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Canine Atopic Dermatitis Market Companies

Name Profile # Employees HQ Website
Dechra View profile - Shrewsbury, Shropshire, United Kingdom, Europe https://www.dechra.co.uk
Biofelix Pharma Group View profile 11-50 Ahmedabad, Gujarat, India, Asia https://biofelixgroup.com
Boehringer Ingelheim International GmbH View profile - - -
Merck & Co., Inc. View profile - - -
Elanco View profile 10001+ Greenfield, Indiana, United States, North America https://www.elanco.com
Bioiberica View profile 251-500 Barcelona, Catalonia, Spain, Europe https://www.bioiberica.com/
Bimeda View profile 1001-5000 Dublin, Dublin, Ireland, Europe https://www.bimeda.com/
Vetoquinol SA View profile 2483 Magny-Vernois, BP 189, Lure cedex, France, 70204 http://www.vetoquinol.com
Toray Industries Inc View profile 48682 Nihonbashi Mitsui Tower 2-1-1, Nihonbashi Muromach, Chuo-ku, Tokyo, Japan, 103-8666 http://www.toray.co.jp
CEVA Inc View profile 424 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 https://www.ceva-dsp.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

Europe canine atopic dermatitis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to canine atopic dermatitis market will help companies and investors design strategic landscapes.


Glucocorticoids was the largest segment with a revenue share of 41.37% in 2024. Horizon Databook has segmented the Europe canine atopic dermatitis market based on glucocorticoids, antihistamines, immunosuppressants, mabs covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe canine atopic dermatitis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe canine atopic dermatitis market databook

  • Our clientele includes a mix of canine atopic dermatitis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe canine atopic dermatitis market , including forecasts for subscribers. This continent databook contains high-level insights into Europe canine atopic dermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe canine atopic dermatitis market size, by country, 2018-2030 (US$M)

Europe Canine Atopic Dermatitis Market Outlook Share, 2024 & 2030 (US$M)

Europe canine atopic dermatitis market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online